TriNetX Secures $40 Million in Series D Funding

Global health research network TriNetX closed $40 million in Series D financing, bringing its total funding to $102 million. The oversubscribed round was led by Merck Global Health Innovation Fund along with new investors Mitsui & Co., Ltd., ITOCHU Technology Ventures, ITOCHU Corporation, and existing investors MPM Capital, F2 Ventures, and Deerfield Management.

The company plans to use the funds to further develop TriNetX’s analytics platform, especially in the areas of artificial intelligence, machine learning, and digital clinical trials, and accelerate its expansion efforts in Europe, Asia, and South America.